Overview

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients

Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess Alefacept in combination with alemtuzumab induction and calcineurin inhibitor and corticosteroid withdrawal.
Phase:
Phase 1
Details
Lead Sponsor:
Northwestern University
Collaborator:
Astellas Pharma Inc
Treatments:
Alefacept
Calcineurin Inhibitors